Structured intelligence on corporate strategy, market moves, and industry signals.
Each entry is a briefing, not a headline: event summary, strategic context, and what to watch next.
A Company Pulse is our reading of what a company says in its own press release, with the questions we would want answered. It is not verified reporting and it is not an endorsement. Pulses are made from press releases we collect from several sources, including Wire. Nobody can pay for a Pulse.
Seaport Therapeutics reported positive topline results from a Phase 1 driving simulation trial of GlyphAllo™, showing no next-morning driving impairment in healthy volunteers.
CodeSignal and Harvard Business Impact announced a partnership on September 9, 2026, to provide hands-on AI and essential skills development to universities worldwide.
UCB's CIMZIA (certolizumab pegol) received FDA Breakthrough Therapy Designation for preventing adverse pregnancy outcomes in women with antiphospholipid syndrome (APS).
